Loading...
Loading...
NXL| Name | Value |
|---|---|
| Revenues | 26.8K |
| Cost of Revenue | 314.7K |
| Gross Profit | -287.9K |
| Operating Expense | 1,009.1K |
| Operating I/L | -1,297.0K |
| Other Income/Expense | 12.5K |
| Interest Income | 0.1K |
| Pretax | -1,284.5K |
| Income Tax Expense | -0.0K |
| Net Income/Loss | -1,284.5K |
Nexalin Technology, Inc. designs and develops neurostimulation products for mental health treatment. Its flagship product, the Nexalin Device, offers non-invasive and drug-free therapy for anxiety and insomnia by emitting a patented frequency-based waveform. The company also focuses on developing Generation 2, a medical device in clinical trials for treating substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia.
